Shareholders Reject Executive Pay at Annual Meeting
WBD has more than doubled off its 52-week low of $9.98.
Summary
Warner Bros. Discovery shareholders rejected the advisory 'Say-on-Pay' proposal for 2025 executive compensation, signaling significant dissatisfaction with management's pay amidst recent financial losses.
Key Events · Corporate Governance and Compliance · WBD
-
Executive Compensation Rejected
Shareholders voted against the non-binding advisory proposal for 2025 executive compensation, with 1.31 billion votes against versus 244.5 million for.
-
Directors Re-elected
All thirteen director nominees were re-elected for one-year terms, though some, like Paul A. Gould and Anthony J. Noto, faced significant 'Votes Withheld' indicating shareholder dissent.
-
Auditor Ratified
PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for fiscal year 2026.
Analysis · WBD · Technology
The non-binding rejection of executive compensation by a substantial majority of shareholders is a strong negative signal. It indicates widespread discontent with how executives are being paid, particularly in light of the company's reported $2.9 billion net loss in Q1 2026 and negative operating cash flow. While not legally binding, this vote puts considerable pressure on the board's compensation committee to reassess executive pay structures and address shareholder concerns, potentially leading to changes in future compensation packages or increased scrutiny of governance.
How filings like this one have moved
In the 30 days to Sep 16, 2026, 35.4% of the 1170 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, WBD was trading at $26.95 on NASDAQ in the Technology sector, with a market capitalization of approximately $67.3B. The 52-week trading range was $9.98 to $30.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.